📢 Exciting News! We successfully raised 6.5M euros in Round C financing! Thanks to our shareholders for their confidence in #OncoDNA's vision. Our objective: double-digit, profitable growth in #personalizedmedicine. Introducing the #OncoDEEPKit, empowering tailored solutions!

🚀 Introducing our new lab solutions portal! 🧬🔬 Access cutting-edge scientific info, research papers, clinical trials, and more in oncology, genetics, and precision medicine. 🔗 https://t.co/ZOokKGMobh #labsolutions #oncology #genetics #precisionmedicine #innovation

We are thrilled to unveil the exceptional quality of the OncoDEEP Kit's HRD assessment presented in our new article "Homologous Recombination Deficiency (#HRD) assessment for clinical management using the OncoDEEP Kit" => https://t.co/ZKLIW0YC5A 💥 #labs #precisionmedicine

OncoDNA is proud to be selected in the Phase 1 of the oncNGS Pre-Commercial Procurement Procedure to develop a novel solution for analysis in liquid biopsies for NGS cancer tests 🧬. #oncodna #precisiononcology #cancerbiomarkers #liquidbiopsy #PCP #HorizonEurope

Our merry team at @OncoDNA is sending their very best wishes for this holiday season🎄and wishing you a sparkling New Year🎉. We are grateful for the trust you have placed in us, and we hope to keep on bringing you closer to your dreams in the year to come✨.

We are delighted to communicate about our collaboration with @LillyPad - Italia to broaden access to biomarker testing for #thyroid cancer patients 🧬. Discover all details in our press release: https://t.co/oh0Avki5DJ #oncodna #oncodeep #cancer #precisiononcology #NGS

OncoDNA is pleased to announce a transformational partnership with the Berkshire and Surrey Pathology Services to facilitate Private NGS testing across UK 🙌. Discover all details in our press release: https://t.co/ypovd0cyTm #oncodna #oncodeep #precisiononcology

We have launched our new #OncoDEEP Kit during the #ESMO in Paris. It enables laboratories with #NGS capabilities to support oncologists in finding the most effective and personalized treatments for their cancer patients🔬. Discover all details: https://t.co/f5BoRrVGrD

We have enjoyed attending the annual #ESMO congress, one of the biggest oncology congresses in the world. We look forward to seeing many of you again next year at ESMO in Madrid, Spain, 20-24 October 2023 🙌. #ESMO #ESMO2022 #oncodeepkit #precisiononcology #cancerbiomarkers

ALK. ROS1. FGFR. NTRK. BRAF. They are all #genefusion biomarkers that can predict a patient’s sensitivity to targeted and hormone therapy. Watch the video to understand how to detect them in patients. https://t.co/zGpOEp7mon #oncology #OncoDEEP #precisionmedicine

Why test patients with metastatic castration-resistant #prostatecancer for #ARV7? This #biomarker is associated with a poor prognostic indicator for the efficacy of #hormonetherapies such as abiraterone or enzalutamide. #OncoDEEP can help detect it => https://t.co/ocmkWnzmIA

Why is it important to test #urothelialcancer #cholangiocarcinoma patients for #FGFRs? Using #DNAseq #RNAseq to detect FGFRs can help predict patient response to #targetedtherapies such as erdafitinib and pemigatinib. #OncoDEEP combines all analyses => https://t.co/cjkplIm8zs

This month, #bladder cancer is in the spotlight: optimize #treatmentstrategy for your patients with advanced or metastatic #urothelialcarcinoma with #OncoDEEP. Identify all clinically relevant #biomarkers in one simple test! #precisionmedicine #oncology #cancer #solidbiopsy

What to do when your patient’s #solidbiopsy is too old, too scarce or not available? 🩸 OncoSELECT, our targeted #liquidbiopsy test is now available for all cancer types to help you optimize #treatment strategies. https://t.co/GOZhJJbZcR #precisionmedecine #oncology #bloodtest

SYNLAB Group continues to push the boundaries of science, by partnering with @OncoDNA to provide a test that helps to predict which patients will respond positively to certain cancer treatments. Read more: https://t.co/8RU7pBwSYf

Today, we were happy to welcome MIT REAP - Regional Entrepreneurship Acceleration Program during their tour of the BioPark in Gosselies. We hope this visit has highlighted the potential of Wallonia in terms of innovation and entrepreneurial capacities 🤩. #oncology #innovation

We are proud to be attending the #AACR2022 in New Orleans and share our research projets in #biomarkertesting and #genomic services 🧬. Don’t hesitate to visit us at booth #3535 👋. Our team is looking forward to meeting you! #biomarkers #precisionmedecine #cancer @AACR

Why test #NSCLC patients for #METex14 unusual splicing, and #ROS #ALK #RET translocations? All are associated with FDA-approved #targetedtherapies. Our #OncoDEEP uses #DNAseq #RNAseq to detect such complex biomarkers & flag patients that are eligible. https://t.co/i4Wgv30vLD

A clinical study highlights the power of combining #NGS and #IHCs to optimize treatment strategies for cancer patients 🧬. Curious to know more about this study? Access the publication here: https://t.co/i9ecxTghBl #OncoDEEP #biomarkertest #precisionmedicine #oncology

Our #OncoDEEP technology is transferred to Synlab laboratories in Germany which will perform comprehensive #biomarker testing of solid tumors and deliver decision support for oncologists. Discover more: https://t.co/FtCFLTiQu0 #oncology #precisionmedicine